Related Experiment Video
Updated: Jul 26, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Astaxanthin inhibits oxidative stress and apoptosis in diabetic retinopathy
Jian Fang1, Wuxia Bai2, Lina Yang1
1Department of Ophthalmology, Xinchang County People's Hospital, Shaoxing City, Zhejiang Province 312500, China.
Background:
The pathophysiology of diabetic retinopathy (DR) is thought to be influenced by oxidative stress. Astaxanthin (ASX) is a natural product with antioxidant effect, but it is not clear whether its mechanism of inhibiting the development of DR is related to anti-oxidation.
Methods:
Rats were intraperitoneally injected with streptozotocin (60 mg/kg) to create DR rat models followed by ASX (20 mg/kg) for 45 days. Retinal tissue was examined by Hematoxylin and Eosin staining. By using Enzyme-linked immunosorbent assay (ELISA), 2,7-Dichlorodrhydrofluorescein diace (DCFH-DA) probes, immunohistochemistry and western blot, it was feasible to evaluate the contents of inflammation-related factors (tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6 and macrophage inhibitory cytokine-1 (MIC-1)), oxidative stress-related indicators (glutathione (GSH), malonic dialdehyde (MDA), glutathione peroxidase (GPx), reactive oxygen species (ROS) and Total antioxidant capacity (T-AOC)), antioxidant enzymes (hemoxgenase-1(HO-1) and Quinone Oxidoreductase 1 (NQO1)), and apoptosis-related proteins (Bcl-2, Bcl2 Associated X Protein (BAX), and cleaved-caspase-3). Additionally, antioxidant proteins downstream of the nuclear factor E2 related factors (Nrf-2) pathway, expression levels of Nrf2/ Kelch-like ECH-associated protein 1(Keap 1) pathway-associated proteins, and nuclear and cytoplasmic levels of Nrf2 were assessed using immunohistochemistry, western blot, or quantitative real-time polymerase chain reaction (qRT-PCR).
Results:
ASX alleviated retinal tissue damage by increasing overall retina thickness and ganglion cell layer (GCL) cell numbers and exerted the anti-inflammatory, anti-oxidative stress, and anti-apoptosis effects in DR rats. Additionally, ASX could inhibit the expression of Keap1, promote the transport of Nrf2 from cytoplasm to nucleus and facilitate the expressions of HO-1, NQO1, γ-glutamylcysteine synthetase, (γ-GCS) and GPx.
Conclusion:
ASX exerted antioxidant effects through Nrf2/keap1 pathway, thereby alleviating apoptosis, inflammation, and oxidative stress in retinal tissues of DR rats.
Insights
Astaxanthin (ASX) protects against diabetic retinopathy (DR) by reducing oxidative stress and inflammation. It activates the Nrf2/Keap1 pathway, alleviating retinal damage and apoptosis in DR rat models.
Area of Science:
- Ophthalmology
- Pharmacology
- Biochemistry
Background:
- Diabetic retinopathy (DR) pathophysiology is linked to oxidative stress.
- Astaxanthin (ASX), a natural antioxidant, has potential therapeutic benefits for DR.
- The precise mechanism of ASX in preventing DR development requires elucidation.
Purpose of the Study:
- To investigate the antioxidant mechanism of Astaxanthin (ASX) in a rat model of diabetic retinopathy (DR).
- To evaluate the effects of ASX on oxidative stress, inflammation, and apoptosis in DR.
- To determine the role of the Nrf2/Keap1 pathway in ASX-mediated protection against DR.
Main Methods:
- Diabetic retinopathy (DR) was induced in rats using streptozotocin.
- Rats were treated with Astaxanthin (ASX) for 45 days.
- Retinal tissues were analyzed for inflammation, oxidative stress, antioxidant enzymes, and apoptosis markers using techniques including ELISA, immunohistochemistry, and western blot, with a focus on the Nrf2/Keap1 pathway.
Main Results:
- Astaxanthin (ASX) treatment alleviated retinal tissue damage, increasing retina thickness and ganglion cell layer (GCL) cell numbers.
- ASX demonstrated anti-inflammatory, anti-oxidative stress, and anti-apoptotic effects in DR rat models.
- ASX inhibited Keap1 expression, promoted Nrf2 nuclear translocation, and upregulated antioxidant enzymes like HO-1, NQO1, γ-GCS, and GPx.
Conclusions:
- Astaxanthin (ASX) exerts antioxidant effects via the Nrf2/Keap1 pathway.
- This mechanism alleviates apoptosis, inflammation, and oxidative stress in the retinal tissues of diabetic retinopathy (DR) rats.
- ASX shows promise as a therapeutic agent for managing diabetic retinopathy (DR).
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
06:51Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
Published on: December 9, 2022